| 2017-11-14 08:39:42|
IOSP 08:39 11/14 11/14/17
Innospec upgraded to Accumulate from Hold at Johnson Rice
Johnson Rice analyst Sean Milligan upgraded Innospec to Accumulate and raised its price target to $84 from $65 following the Q3 report. The analyst said Innospec reported stronger-than-expected free-cash-flow generation and improving operating results in Performance Chemicals. Milligan believes the multiple with expand as free-cash-flow continues to improve and would use pullbacks to create new positions.